Shuttle Pharma gets Nasdaq noncompliance notice over late quarterly filing
SHPH•Remediation timeline and trading status
A remediation plan is due by Oct. 27, 2026; Nasdaq may grant an exception through Feb. 22, 2027.
Trading continues for now, though a noncompliance indicator will be disseminated and the issuer will appear on Nasdaq’s list around Sept. 4, 2026.
Nasdaq notice over late Form 10-Q filing
Shuttle Pharmaceuticals received a Nasdaq noncompliance notice for missing the Form 10-Q filing deadline for the quarter ended June 30, 2026.
The late filing breaches Nasdaq Listing Rule 5250(c)(1), raising delisting risk if compliance is not restored.
